US NRC FR Notice Withdrawl of KI Draft NUREG

[Mike Grissom <mikeg@SLAC.Stanford.EDU>]

radsafer's,

Potassium iodide remains in the emergency preparedness
arena, but the US Nuclear Regulatory Commission is
withdrawing the draft NUREG for completing further
revisions as posted in today's US Federal Register
(extract shown here):

----------
Federal Register: October 16, 1998 (Volume 63,
 Number 200).

...
 Page: 55653

            NUCLEAR REGULATORY COMMISSION

    Assessment of the Use of Potassium Iodide (KI)
            As a Public Protective Action
          During Severe Reactor Accidents;
              Withdrawal of Draft NUREG

...
SUMMARY: On July 20, 1998, the NRC announced the
availability of Draft NUREG-1633, "Assessment of
the Use of Potassium iodide (KI) As a Public
Protective Action During Severe Reactor Accidents,"
and requested comments by September 14, 1998. Based
on the many useful public comments received, a
substantially revised document that takes those
comments into account will be issued in its place,
and the draft NUREG is therefore being withdrawn.

FOR FURTHER INFORMATION CONTACT:
Aby S. Mohseni, Incident Response Division, Office
for Analysis and Evaluation of Operational Data, U.S.
Nuclear Regulatory Commission, Washington, D.C.
20555-0001, telephone 301-415 6409, e-mail
asm@nrc.gov.

SUPPLEMENTARY INFORMATION: On June 26, 1998, the
Commission granted a petition for rulemaking on the
use of KI around nuclear power plants and directed
the staff to issue the draft NUREG-1633 for public
comment. On September 30, 1998, the Commission
directed the staff to issue a Federal Register
notice stating that, in light of the many useful
public comments on draft NUREG-1633, a substantially
revised document that takes those comments into
account will be issued in its place, and that the
draft NUREG is therefore being withdrawn. The
reissued document will include an improved discussion
on how the practical problems in KI stockpiling,
distribution, and use are handled in the States that
already use KI as a supplement and in the numerous
nations which use KI as a supplement. A discussion,
in some detail, of the various guidance documents of
the World Health Organization and International Atomic
Energy Agency, as well as the U.S. Food and Drug
Administration, on this subject will also be included
in the revised document. The revised NUREG will be
consistent with the policy adopted by the Commission
in response to the petition for rulemaking and will
fairly discuss the factors that need to be weighed in
the State and local decisions. The staff anticipates
making the revised draft NUREG-1633 in its final form
by September, 1999. Subsequently, the staff will
develop an information brochure based on NUREG-1633
to assist State and local planners in reaching an
informed decision as to whether KI is an appropriate
protective supplement.

Dated at Rockville, Maryland, this 2nd day of October
1998.

For the Nuclear Regulatory Commission.

Frank J. Congel,
Director, Incident Response Division, Office for
Analysis and Evaluation of Operational Data.
... 

----------
Most US Federal Register documents can be readily
found using the GPO Web site at URL:

http://www.access.gpo.gov/su_docs/aces/aces140.html


************************************************************************
The RADSAFE Frequently Asked Questions list, archives and subscription
information can be accessed at http://www.ehs.uiuc.edu/~rad/radsafe.html